Fixed dose combination of dapagliflozin, glimepiride and extended‐release metformin tablets in patients with type 2 diabetes poorly controlled by metformin and glimepiride: A phase III , open label, randomized clinical study in India
2025; Wiley; Linguagem: Inglês
10.1111/dom.16218
ISSN1463-1326
AutoresRakesh Sahay, Dinesh Gangwani, Manish Singh, Sandeep K. Gupta, Narendra Kale, Manoj Srivastava, Prakash Kurmi, Jayesh Ambaliya, Nilesh Lomte, Sandip Gofne, Saurabh Agarwal, Priyanka Kashid, Vikas Agarwal, Pradeep Rai, Surendra Sharma, L. Sreenivasa Murthy, Mandodari Rajurkar, Shruti Saha, Piyush M. Patel, Dipak D. Patil, Pravin Ghadge, Lalit Lakhwani, Suyog Mehta, Sadhna J. Joglekar,
Tópico(s)Diabetes Management and Research
Referência(s)